Ask Warren

MedPacto

235980 · KOSDAQ · ₩235980 · 메드팩토

₩3,050▲ ₩80 (2.69%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩1B₩1.3B₩1.4B₩1.2B₩840M₩430M₩0₩0
Cost of sales₩991M₩1.2B₩1.3B₩1.1B₩662M₩490M₩0₩0
Gross profit₩58M₩91M₩165M₩102M₩178M−₩60M₩0₩0
Operating income−₩3.6B−₩4.2B−₩2.9B−₩4.7B−₩2.6B−₩3.8B−₩4.8B−₩2.2B
Net income₩566M−₩3.8B−₩8.3B−₩2.3B₩1.1B−₩3.4B−₩18B₩2.9B
Net income to shareholders−₩3.2B−₩3.8B−₩2.7B−₩4.5B−₩2.3B−₩3.4B−₩4.4B−₩1.8B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩42B₩45B₩49B₩52B₩55B₩56B₩61B₩66B
Current assets₩39B₩42B₩45B₩48B₩52B₩54B₩57B₩62B
Cash and equivalents₩6.5B₩8.8B₩12B₩18B₩23B₩11B₩15B₩30B
Total liabilities₩2.8B₩2.8B₩2.7B₩3.2B₩3B₩1.1B₩3B₩10B
Current liabilities₩1.7B₩1.6B₩1.4B₩1.8B₩1.4B₩910M₩1.4B₩8.5B
Borrowings₩1.5B₩1.6B₩1.7B₩1.3B₩1.5B₩0₩1.5B₩1.4B
Total equity₩39B₩43B₩46B₩48B₩52B₩55B₩58B₩56B
Shareholders' equity₩39B₩43B₩46B₩48B₩52B₩55B₩58B₩56B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩2.3B−₩2.9B−₩2.5B−₩4.5B−₩3B−₩3.4B−₩2.7B−₩1.5B
Capital spending₩2.6M₩41M————₩252M₩59M
Free cash flow−₩2.3B−₩3B−₩2.5B−₩4.5B−₩3B−₩3.4B−₩3B−₩1.6B

Consolidated where available. Amounts in won.

Also known as: MedPacto / 메드팩토 / 235980 / KRX:235980

Source: KRX statistical information